VivoSeq
Gastroenterology

Acute Diarrhea

15

Pipeline Programs

1

Active Trials

4

Companies Involved

Acute Diarrhea is an emerging landscape with 15 programs across 4 companies. The most active players are Johnson & Johnson, Pfizer, Sanofi. 5 therapies are approved with 6 more in late-stage development.

Pipeline Metrics

Competitive Density

42/100

Pipeline Velocity

6/100

Mech. Concentration

33/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Trial Status

17

clinical trials

Completed15 · 88%
Unknown status1 · 6%
Recruiting1 · 6%

Trial Activity

17 trials

Oral Zinc for the Treatment of Acute Diarrhea in US Children
Completed··N/A·NCT01198587·71 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)